Richard Klausner - Jun 8, 2021 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role: Director
Signature: /s/ Charles Newton, as Attorney-in-fact
Stock symbol: LYEL
Transactions as of: Jun 8, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/10/2022, 04:08 PM
Next filing: Jun 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LYEL	Common Stock						2.97M	Jun 8, 2021	Direct
holding	LYEL	Common Stock						1M	Jun 8, 2021	Trustee	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LYEL	Option (right to buy)	Award	$0	+65K		$0.00	65K	Jun 8, 2022	Common Stock	65K	$5.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 250,000 shares held by each of The Ariella Klausner Delaware Trust, The Eli Klausner Delaware Trust, The Isaac Klausner Delaware Trust, and The Olivia Klausner Delaware Trust. The Reporting Person is a trustee of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein.
F2	The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person providing continuous service through such date.

Content

Consists of 250,000 shares held by each of The Ariella Klausner Delaware Trust, The Eli Klausner Delaware Trust, The Isaac Klausner Delaware Trust, and The Olivia Klausner Delaware Trust. The Reporting Person is a trustee of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein.

The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person providing continuous service through such date.